Focuses on discovering and developing novel small molecule cancer therapeutics.

Private Company

Total funding raised: $40M

About

Focuses on discovering and developing novel small molecule cancer therapeutics.

Small Molecules

Funding History

2
Total raised:$40M
Series B$25M
Series A$15M